持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/24 | 3,390 | 3,440 | 3,385 | 3,420 | +50 | +1.5% | 35,200 |
| 2023/01/23 | 3,330 | 3,380 | 3,330 | 3,370 | +55 | +1.7% | 29,500 |
| 2023/01/20 | 3,325 | 3,350 | 3,310 | 3,315 | -5 | -0.2% | 20,900 |
| 2023/01/19 | 3,320 | 3,345 | 3,305 | 3,320 | -30 | -0.9% | 24,100 |
| 2023/01/18 | 3,315 | 3,375 | 3,310 | 3,350 | +50 | +1.5% | 29,000 |
| 2023/01/17 | 3,275 | 3,310 | 3,275 | 3,300 | +10 | +0.3% | 25,500 |
| 2023/01/16 | 3,275 | 3,315 | 3,275 | 3,290 | -10 | -0.3% | 22,400 |
| 2023/01/13 | 3,275 | 3,315 | 3,275 | 3,300 | +25 | +0.8% | 28,200 |
| 2023/01/12 | 3,250 | 3,290 | 3,250 | 3,275 | +25 | +0.8% | 15,200 |
| 2023/01/11 | 3,210 | 3,265 | 3,210 | 3,250 | +60 | +1.9% | 21,200 |
| 2023/01/10 | 3,270 | 3,295 | 3,190 | 3,190 | -100 | -3% | 27,000 |
| 2023/01/06 | 3,260 | 3,300 | 3,240 | 3,290 | +25 | +0.8% | 24,100 |
| 2023/01/05 | 3,320 | 3,320 | 3,265 | 3,265 | -75 | -2.2% | 30,000 |
| 2023/01/04 | 3,435 | 3,435 | 3,340 | 3,340 | -140 | -4% | 33,000 |
| 2022/12/30 | 3,515 | 3,530 | 3,480 | 3,480 | -30 | -0.9% | 16,400 |
| 2022/12/29 | 3,455 | 3,510 | 3,450 | 3,510 | +5 | +0.1% | 17,500 |
| 2022/12/28 | 3,440 | 3,510 | 3,440 | 3,505 | +40 | +1.2% | 14,000 |
| 2022/12/27 | 3,465 | 3,500 | 3,450 | 3,465 | +15 | +0.4% | 30,300 |
| 2022/12/26 | 3,450 | 3,455 | 3,415 | 3,450 | +30 | +0.9% | 23,100 |
| 2022/12/23 | 3,400 | 3,445 | 3,400 | 3,420 | ±0 | ±0% | 23,700 |
| 2022/12/22 | 3,395 | 3,440 | 3,380 | 3,420 | +30 | +0.9% | 36,800 |
| 2022/12/21 | 3,400 | 3,420 | 3,365 | 3,390 | -10 | -0.3% | 38,200 |
| 2022/12/20 | 3,430 | 3,455 | 3,380 | 3,400 | -10 | -0.3% | 37,400 |
| 2022/12/19 | 3,380 | 3,435 | 3,380 | 3,410 | -5 | -0.1% | 34,200 |
| 2022/12/16 | 3,365 | 3,425 | 3,365 | 3,415 | +10 | +0.3% | 54,000 |
| 2022/12/15 | 3,390 | 3,415 | 3,390 | 3,405 | +5 | +0.1% | 16,600 |
| 2022/12/14 | 3,390 | 3,415 | 3,390 | 3,400 | +20 | +0.6% | 20,700 |
| 2022/12/13 | 3,360 | 3,415 | 3,360 | 3,380 | +20 | +0.6% | 28,100 |
| 2022/12/12 | 3,360 | 3,385 | 3,345 | 3,360 | -5 | -0.1% | 23,800 |
| 2022/12/09 | 3,285 | 3,380 | 3,285 | 3,365 | +40 | +1.2% | 31,500 |
| 2022/12/08 | 3,320 | 3,335 | 3,295 | 3,325 | +5 | +0.2% | 31,800 |
| 2022/12/07 | 3,300 | 3,350 | 3,290 | 3,320 | +10 | +0.3% | 27,000 |
| 2022/12/06 | 3,325 | 3,335 | 3,290 | 3,310 | +15 | +0.5% | 37,100 |
| 2022/12/05 | 3,280 | 3,295 | 3,250 | 3,295 | +15 | +0.5% | 46,800 |
| 2022/12/02 | 3,350 | 3,350 | 3,245 | 3,280 | -90 | -2.7% | 49,900 |
| 2022/12/01 | 3,415 | 3,415 | 3,340 | 3,370 | -10 | -0.3% | 36,900 |
| 2022/11/30 | 3,380 | 3,400 | 3,365 | 3,380 | -10 | -0.3% | 49,300 |
| 2022/11/29 | 3,420 | 3,420 | 3,380 | 3,390 | -55 | -1.6% | 32,500 |
| 2022/11/28 | 3,450 | 3,465 | 3,410 | 3,445 | -10 | -0.3% | 32,700 |
| 2022/11/25 | 3,420 | 3,455 | 3,405 | 3,455 | +55 | +1.6% | 30,100 |
| 2022/11/24 | 3,400 | 3,450 | 3,395 | 3,400 | +30 | +0.9% | 41,400 |
| 2022/11/22 | 3,295 | 3,380 | 3,295 | 3,370 | +95 | +2.9% | 62,800 |
| 2022/11/21 | 3,285 | 3,290 | 3,240 | 3,275 | +20 | +0.6% | 37,700 |
| 2022/11/18 | 3,225 | 3,265 | 3,225 | 3,255 | +45 | +1.4% | 35,100 |
| 2022/11/17 | 3,160 | 3,230 | 3,160 | 3,210 | +50 | +1.6% | 24,700 |
| 2022/11/16 | 3,160 | 3,180 | 3,145 | 3,160 | -10 | -0.3% | 34,000 |
| 2022/11/15 | 3,165 | 3,200 | 3,165 | 3,170 | +15 | +0.5% | 28,900 |
| 2022/11/14 | 3,155 | 3,180 | 3,150 | 3,155 | -15 | -0.5% | 27,600 |
| 2022/11/11 | 3,175 | 3,185 | 3,145 | 3,170 | +15 | +0.5% | 37,800 |
| 2022/11/10 | 3,125 | 3,175 | 3,090 | 3,155 | +30 | +1% | 45,000 |
451～
500
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 330,500円 | +3.0% | +27.5% | 2.42% | 20.93倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,900円 | +52.1% | +23.3% | 0.00% | 20.01倍 | 3.84倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 472,500円 | +12.0% | +28.1% | 2.54% | 26.04倍 | 1.10倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,500円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,800円 | +197.7% | - | 0.00% | 46.51倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
